AS1411 aptamer-modified theranostic liposomes co-encapsulating manganese oxide nano-contrast agent and paclitaxel for MRI and therapy of cancer

With the advantages and development of MRI nano-contrast agents (CAs), increasing number of MRI-based theranostic nanoparticles have emerged. Liposome, as a biosafe nanocarrier has been used phase III trial for cancer treatment. In this study, liposome was employed as a nanocarrier to co-encapsulate...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jingjing, Li, Qing, He, Meijuan, Ding, Fan, Cai, Lulu, Zhao, Mingming, Dong, Lina, Wang, Qi, Xu, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2019
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074166/
https://www.ncbi.nlm.nih.gov/pubmed/35530716
http://dx.doi.org/10.1039/c9ra06878c

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074166/
https://www.ncbi.nlm.nih.gov/pubmed/35530716
http://dx.doi.org/10.1039/c9ra06878c

Ejemplares similares